Autoimmune diseases and autoimmunity post-bone marrow transplantation

Bone Marrow Transplantation

Volumn 22, Issue 9, 1998, Pages 873-881

  Sherer, Y ^a   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune cytopenias; Autoimmune diseases; Graft versus host disease; Hypothyroidism; Myasthenia gravis

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOPENIA; DONOR; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GRAFT VERSUS HOST REACTION; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE DEFICIENCY; MICROCHIMERISM; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THYMUS DISEASE;

EID: 0031769146     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701437     Document Type: Review

References (83)

1. Ferrara JLM, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
2. Passweg JR, Tiberghien P, Cahn JY et al. Graft-versus-leukaemia effects in T lineage and B lineage acute lymphoblastic leukaemia. Bone Marrow Transplant 1998; 21: 153-158.
3. Shlomchik WD, Emerson SG. The immunobiology of T cell therapies for leukemias. Acta Haematol 1996; 96: 189-213.
4. Sherer Y, Shoenfeld Y. Stem cells transplantation-a cure for autoimmune diseases. Lupus 1998; 7: 137-140.
5. Tyndall A, Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 1996; 55: 149-151.
6. Marmont AM. Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus? Lupus 1993; 2: 151-156.
7. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390-392.
8. Shoenfeld Y, Isenherg D. The Mosaic of Autoimmunity. Elsevier: Amsterdam. 1989.
9. Parkman R. Is chronic graft versus host disease an autoimmune disease? Curr Opin Immunol 1993; 5: 800-803.
10. Woo SB, Lee SJ, Schubert MM. Graft-vs.-host disease. Crit Rev Oral Biol Med 1997; 8: 201-216.
11. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E. Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long term surviving patients. Transplantation 1988; 46: 238-240.
12. Lister J, Messner H, Keystone E et al. Autoantibody analysis of patients with graft versus host disease. J Clin Lab Immunol 1987; 24: 19-23.
13. Holmes JA, Livesey SJ, Bedwell AE et al. Autoantibody analysis in chronic gruft-versus-host disease. Bone Marrow Transplant 1989; 4: 529-531.
14. Ghayur T, Seemayer TA, Xenocostas A, Lapp WS. Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease. Am J Pathol 1988; 133: 39-46.
15. Doria G, Mancini C, Utsuyama M et al. Aging of the recipients but not of the bone marrow donor enhances autoimmuntiy in syngeneic radiation chimeras. Mech Ageing Der 1997; 95: 131-142.
16. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997; 90: 4705-4709.
17. Hess AD, Fischer AC. Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease. Transplantation 1989; 48: 895-900.
18. Sherer Y, Bar-Dayan Y, Shoenfeld Y. Thymoma, thymic hyperplasia. thymectomy and autoimmune diseases. Int J Oncol 1997; 10: 939-943.
19. Sherer Y, Bar-Dayan Y, Shoenfeld Y, Thymectomy and autoimmune diseases - the dual connection. Semin Clin Immnnol 1997; 1: 5-11.
20. Hinterberger-Fiseher M, Kier P, Spona J et al. Prolactin:; a possible mediator of graft-versus-host disease following allogeneic Done marrow transplantation in humans. Bone Marrow Transplant 1994; 14: 403-406.
21. Buskila D, Sukenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991; 26: 118-123.
22. Blank M, Krause I, Buskila D et al. Bromocriptine immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 1995; 162: 114-122.
23. Benker G, Schafer U, Hermanns U. Allogeneic bone marrow transplantation in adults: endocrine sequelae after 1-6 years. Acta Endocrinol 1989; 120: 37-42.
24. Shalet SM, Didi M, Ogilvy-Stuart AL. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol 1995; 42: 333-339.
25. Al-Fiar FZ, Colwill R, Lipton JH et al. Abnormal thyroid stimulating hormone levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant 1997; 19: 1019-1022.
26. Sanders JE. Late effects in children receiving total body irradiation for bone marrow transplantation. Radiother Oncol 1990: 18 (Suppl. 1): 82-87.
27. Carlson K, Lonnerholm G, Smedmyr B. Thyroid function after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10: 123-127.
28. Aldouri MA, Ruggier R, Epstein O, Prentice HG. Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol 1990; 74: 118-120.
29. Ichihahi T, Yoshida H, Kiyoi H et al. Development of hyperthyroidism in donor and recipient after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 397-398.
30. Thomson JA, Wilson RM, Franklin IM. Transmission of thyrotoxicosis of autoimmune type by sibling allogeneic bone marrow transplant. Eur J Endocrinol 1995; 133: 564-566.
31. Holland FJ, McConnor JK, Volpe R, Saunders EF. Concordant Graves' disease after bone marrow transplantation: implications for puthogenesis. J Clin Endocrinol Metab 1991; 72: 837-840.
32. Kishimoto Y, Yamamoto Y, Ito T et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1041-1043.
33. Yoshikawa N, Nishikawa M, Mori S et al. Simultaneous xenotransplantation of human Graves' thyroid tissue and autologous bone marrow cells in severe combined imnumodeficient mice: successful reconstitution of human Graves' hyperthyroidism. Eur J Endocrinol 1997; 136: 213-222.
34. Smith CIE, Aarli JA, Biberfeld P et al. Myasthenia gravis after bone-marrow transplantation. New Engl J Med 1983; 309: 1565-1568.
35. Seely E, Drachman D, Smit BR. Post bone marrow transplantation myasthenia gravis: evidence for acetylcholine receptor abnormality. Blood 1984; 64 (Suppl. 1): 221.
36. Boliger GB, Sullivan KM, Spence AM et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986; 36: 1087-1091.
37. Grau JM, Casademont J, Monforte R et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of new case and pathogenetic considerations. Bone Marrow Transplant 1990; 5: 435-437.
38. Melms A, Faul C, Sommer N et al. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 1992; 9: 78-79.
39. Shimoda K, Gondo H, Harada M et al. Myasthenia gravis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 155-156.
40. Adams C, August CS, Maguire H, Sladky JT. Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995; 12: 58-61.
41. Zaja F, Russo D, Silvestri F et al. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 1995; 151: 649-650.
42. Mackey JR, Desai S, Larratt L et al. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997; 19: 939-942.
43. Lefvert A, Bjorkholm M. Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow transplantation. New Engl J Med 1987; 317: 170.
44. Smith CI, Norberg R, Moller G et al. Autoantibody formation after bone marrow transplantation. Comparison between acetylcholine receptor antibodies and other autoantibodies and analysis of HLA and Gm markers. Eur Neurol 1989; 29: 128-134.
45. Smith CIE, Hammarstrom L, Lefvert AK. Bone marrow grafting induces acetylcholine receptor antibody formation. Lancet 1985; I: 978.
46. Tamura T, Kanamori H, Yamazaki E et al. Cold agglutinin disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 321-323.
47. Meloni G, Andrizzi C, Vignetti M et al. Autoimmune haemolytic anaemia in a patient with acute myeloid leukaemia treated with low-close interleukin-2 after autologous bone marrow transplantation. Blood 1995; 86: 837-838.
48. Tosi P, Bandini G, Tazzari P et al. Autoimmune neutropenia after unrelated bone marrow transplantation. Bone Marrow Transplant 1994; 14: 1003-1004.
49. Klumpp TR. Antibody-mediated neutropenia following bone marrow transplantation, Int J Clin Lab Res 1993; 23: 4-7.
50. Garcia Vela JA, Ona F, Monteserin MC et al. Autoimmune thrombocytopenia after autologous bone marrow transplantation. Am J Hematol 1994; 46: 375.
51. Sivakumaran M, Hutchinson RM, Pringle H et al. Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. Bone Marrow Transplant 1995; 15: 531-536.
52. Lee SJ, Churchill WH, Konugres A et al. Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation treatment with anti-D immunoglobulin. Bone Marrow Transplant 1997; 19: 173-174.
53. Katayama N, Oda K, Furuta I et al. Autoimmune thrombocytopenia after allogeneic bone marrow transplantation: case report. Nippon Ketsueki Gakkautoimmune Zasshi 1988; 51: 137-141.
54. Minchinton RM, Waters AH. Autoimmune thrombocytopenia and neutropenia after bone marrow transplantation. Blood 1985; 66: 752.
55. De Lord C, Marsh JCW, Smith JG et al. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia. Bone Marrow Transplant 1996; 18: 237-239.
56. Bashey A, Owen I, Lucas GF et al. Late onset immune paneytopenia following bone marrow transplantation. Br J Haematol 1991; 78: 268-274.
57. Klumpp TR, Caligiuri MA, Rabinowe SN et al. Autoimmune pancytopenia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 6: 445-447.
58. Drobyski WR, Potluri J, Sauer D, Gottschall JL. Autoimmune haemolytic anaemia following T cell depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1093-1099.
59. Chen FE, Owen I, Savage D et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997; 19: 491-495.
60. Klumpp TR, Herman JH. Autoimmune neutropenia after bone marrow transplantation. Blood 1993; 82: 1035-1038.
61. Klumpp TR, Block CC, Caligiuri MA et al. Immune-mediated cytopenia following bone-marrow transplantation: Case reports and review of the literature. Medicine 1992; 71: 73-79.
62. Sohngen D, Heyll A, Meckenstock G et al. Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation. Am J Hematol 1994; 47; 143-144.
63. Lampeter EF, Homherg M, Quabeck K et al. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993; 341: 1243-1244.
64. Kamisato T, Tsubaki K, Adachi Y. Autoimmune hepatitis after cytomegalovirus infection in a bone marrow-transplanted patient. Am J Gastroenterol 1997; 92: 1238-1239.
65. Burger J, Gmur J, Bruckner Tuderman L. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation? Bone Marrow Transplant 1992; 9: 139-141.
66. Delbaldo C, Rieckhoff Cuntoni L, Helg C, Saurat JH, Billous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 377-379.
67. Latal Hajnal B, Lips U, Friedrich W et al. Addison disease 10 years after bone marrow transplantation for Wiskot-Aldrich syndrome. Eur J Pediatr 1995; 154: 729-731.
68. Fullerton SH, Woodley DT, Smoller BR, Anhalt GJ, Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA 1992; 267: 1500-1502.
69. Lambertenghi Deliliers G, Annaloro C, Della Volpe A et al. Multiple autoimmune events after autologous bone marrow transplantation. Bone Marrow Transplant 1997; 19: 745-747.
70. Vialettes B, Maraninchi D, San Marco MP. Autoimmune polyendocrine failure type 1 (insulin-dependent) diabetes mellitus and hypothyroidism after allogeneic bone marrow transplantation. Diabetologia 1993; 36: 541-546.
71. Soderberg C, Sumitran Karuppan S, Ljungman P, Moller E. CD13-specitic autoimnumity in cytomegalovirus-infected immunocompromiscd patients. Transplantation 1996; 61: 594-600.
72. Soderberg C, Larsson S, Rozell BL et al. Cytomegaloviiusinduced CD13-specific autoimmunity- a possible cause of chronic graft versus host disease. Transplantation 1996; 61: 600-609.
73. Naucler CS, Larsson S, Moller E. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996; 152: 175-192.
74. Jacobsen N, Andersen HK, Skinhoj P et al. Correlation between donor cytomegulovirus immunity and chronic graft -versus-host disease after allogeneic bone marrow transplantation. Scand J Haematol 1986; 36: 499-506.
75. Larsson S, Soderberg-Naucler C, Moller E. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission. Transplantation 1998; 65: 411-415.
76. Corbi C, Traineau R, Esperou H et al. Prevalence and clinical features of hepatitis G virus infection in bone marrow allograft recipients. Bone Marrow Transplant 1997; 20: 965-968.
77. Snowden JA, Atkinson K, Kearney P et al. Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient. Bone Marrow Transplant 1997; 20: 71-73.
78. Delukina M, Kapelushnik Y, Or R et al. Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura. Med Oncol 1995; 12: 125-127.
79. Sturfelt G, Lenhoff S, Sallerfors B et al. Transplantation with allogeneic bone marrow from a donor with systemic lupus erythematosus: successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis 1996; 55: 638-641.
80. Schlansky R, DeHoratius RJ, Pincus T, Tung KSK. Plasmapheresis in systemic lupus erythematosus - a cautionary note. Arthritis Rheum 1981; 24: 49-53.
81. Artlett CM, Welsh KI, Black CM, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997; 47: 17-22.
82. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1997; 351: 559-562.
83. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. New Engl J Med 1998; 338: 1186-1191.